Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
Eligibility Criteria
- * Age ≥18 years
- * ≥ 12 months and ≤ 36 months post-AlloSCT
- * Donor sources: matched related, matched unrelated, cord blood
- * Any malignant hematological disease including acute leukemia, myelodysplastic syndrome, non-Hodgkin's lymphoma, Hodgkin's lymphoma, chronic lymphocytic leukemia, chronic myeloid leukemia, multiple myeloma, and myeloproliferative disorders.
- * Any conditioning regimen
- * Any planned immunosuppressive prophylactic regimen
- * Patients with chronic graft-versus-host disease on stable immunosuppression
- * Ability to understand and the willingness to sign a written informed consent.
- * Negative pregnancy test in female patients of childbearing potential
- * Patients who had zoster after an allogeneic transplant and prior to enrollment
- * Patients who are currently pregnant
- * History of allergic reactions attributed to compounds of similar chemical or biologic composition to the recombinant zoster vaccine, Shingrix, or other agents used in study.
- * Patients who have had a relapse of their primary hematological disease
- * Previous allogeneic stem cell transplantation
- * Acute disease at the time of vaccination
- * Thrombocytopenia that in the judgment of the investigator would make intramuscular injection unsafe.
Ages Eligible for Study
to
Sexes Eligible for Study
ALL
Accepts Healthy Volunteers
No